BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/15/2026 7:46:23 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-08-14 02:58 |
|
Peer-Review Started |
|
2025-08-14 02:58 |
|
First Decision by Editorial Office Director |
|
2025-08-25 07:31 |
|
Return for Revision |
|
2025-08-25 07:31 |
|
Revised |
|
2025-09-05 09:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-17 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-17 04:12 |
|
Articles in Press |
|
2025-12-17 04:12 |
|
Edit the Manuscript by Language Editor |
|
2025-12-19 03:07 |
|
Typeset the Manuscript |
|
2026-01-14 02:40 |
|
Publish the Manuscript Online |
|
2026-01-15 07:46 |
| ISSN |
2220-3192 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
GLORY-1: The obesity buster and its potential side effects - discussing the similarities and differences with glucagon-like peptide-1 inhibitors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chen-Xi Deng, Zi-Ming Chen, Ying-Xuan Tang, Zhe-Xing Xi, Shuai-Yan Wang, Hai-Yan Wu, Bin Xu and Tian-Cheng Xu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Natural Science Foundation, Youth Science Fund Project |
82305376 |
| the Youth Talent Support Project of the China Acupuncture and Moxibustion Association |
2024-2026ZGZJXH-QNRC005 |
| the 2024 Jiangsu Province Youth Science and Technology Talent Support Project |
JSTJ-2024-380 |
| 2025 Jiangsu Provincial Science and Technology Think Tank Program Project |
JSKX0125035 |
| The National College Student Innovation and Entrepreneurship Training Program |
202410315020Z |
|
| Corresponding Author |
Tian-Cheng Xu, CEO, Chairman, Head, MD, PhD, President, Professor, Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, No. 138 Xianlin Avenue, Qixia District, Nanjing 210023, Jiangsu Province, China. xtc@njucm.edu.cn |
| Key Words |
Obesity; Glucagon receptor; Glucagon-like peptide-1 receptor; Mazdutide; GLORY-1 study |
| Core Tip |
Mazdutide has breakthrough value in terms of weight loss and metabolic regulation. Future research needs to further investigate its specific mechanisms to promote clinical translation. |
| Publish Date |
2026-01-15 07:46 |
| Citation |
Deng CX, Chen ZM, Tang YX, Xi ZX, Wang SY, Wu HY, Xu B, Xu TC. GLORY-1: The obesity buster and its potential side effects - discussing the similarities and differences with glucagon-like peptide-1 inhibitors. World J Pharmacol 2026; 15(1): 113080 |
| URL |
https://www.wjgnet.com/2220-3192/full/v15/i1/113080.htm |
| DOI |
https://dx.doi.org/10.5497/wjp.v15.i1.113080 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
